Phaseline

Companies › Cristália Produtos Químicos Farmacêuticos Ltda.

Cristália Produtos Químicos Farmacêuticos Ltda.: clinical trials, targets and expected readouts

1 active drug program in 1 registered trial: 1 Phase 1; Neurology; next expected readout Dec 2027.

Open in Phaseline: competitors, likelihood bands and readouts Company report

Programs

DrugTargetHighest phaseConditionsNext expected readout
CRT100–Phase 1Thoracic Spinal Cord InjuryDec 2027

Trials

Registry idDrugPhaseConditionsAreaExpected readout
NCT05739734CRT100Phase 1Thoracic Spinal Cord InjuryNeurologyDec 2027

Targets

No annotated target.

Companies with the same targets

–

Programs group the company's trials by drug; the target and mechanism come from Open Targets and ChEMBL via Open Targets; expected readouts are Phaseline's estimate from the registry's primary completion date. Facts from the registries only; the approval likelihood, shown as a band with its track record, is in the app.